PLAY PODCASTS
Annals On Call Podcast

Annals On Call Podcast

American College of Physicians

191 episodesEN-US

Show overview

Annals On Call Podcast has been publishing since 2018, and across the 8 years since has built a catalogue of 191 episodes. That works out to roughly 75 hours of audio in total. Releases follow a fortnightly cadence.

Episodes typically run twenty to thirty-five minutes — most land between 21 min and 27 min — and the run-time is fairly consistent across the catalogue. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-US-language Health & Fitness show.

The show is actively publishing — the most recent episode landed 1 weeks ago, with 9 episodes already out so far this year. Published by American College of Physicians.

Episodes
191
Running
2018–2026 · 8y
Median length
24 min
Cadence
Fortnightly

From the publisher

Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.

Latest Episodes

View all 191 episodes

Clinical Mastery in Primary Care

May 4, 202618 min

Physicians Not Providers

Apr 20, 202619 min

Managing Inpatient Hyponatremia Part 2

Apr 6, 202628 min

Managing Outpatient Hyponatremia Part 1

Dr. Centor discusses hyponatremia in the outpatient setting with Dr. Joel Topf.

Mar 16, 202619 min

Alzheimer Disease: A Diagnostic Challenge

Dr. Centor discusses the diagnosis of Alzheimer disease with Dr. Gayatri Devi.

Mar 2, 202621 min

Hyponatremia Correction: How Fast Is Too Fast?

Dr. Centor discusses hyponatremia correction rates with Dr. Dustin Mark.

Feb 16, 202621 min

The Role of Corticosteroids in Severe Pneumonia

Dr. Centor discusses the role of corticosteroids in the treatment of community-acquired pneumonia with Dr. Michael Klompas.

Feb 2, 202620 min

Dulaglutide, Semaglutide, and Tirzepatide: How do Gastrointestinal Side Effects Compare?

Dr. Centor discusses the comparative risk for severe gastrointestinal adverse events associated with dulaglutide, semaglutide, and tirzepatide with Dr. Wajd Alkabbani.

Jan 19, 202621 min

Mediterranean Diet in the Management of Irritable Bowel Syndrome

Dr. Centor discusses dietary interventions for patients with irritable bowel syndrome with Dr. Imran Aziz.

Jan 5, 202623 min

Complications Associated With Transvenous Cardiac Implantable Devices

Dr. Centor discusses complications of cardiac implantable electronic devices with Dr. Peter Zimetbaum.

Dec 15, 202525 min

Cost-Effectiveness of Weight Loss Drugs for Knee Osteoarthritis

Dr. Centor discusses the use of weight loss drugs to treat patients with knee osteoarthritis with Dr. David Felson.

Dec 1, 202525 min

Palliative Care: A Family Perspective

Dr. Centor discusses a family perspective on palliative care with Ms. Monica Wright, the author of an On Being a Patient essay.

Nov 17, 202519 min

What You May Have Missed in 2024: Part 3

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

Nov 3, 202515 min

What You May Have Missed in 2024 - Part 2

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

Oct 20, 202513 min

High-Concentration Cannabinoids: Are They Safe?

Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.

Oct 6, 202529 min

What You May Have Missed in 2024: Part 1

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

Sep 15, 202520 min

Fibrillation - When Ablation is the Way to Go

Dr. Centor discusses the role of ablation in the management of patients with atrial fibrillation with Dr. Peter Zimetbaum.

Sep 1, 202522 min

Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes

Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.

Aug 18, 202529 min

Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide

Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.

Aug 4, 202521 min

Diagnosing Primary Aldosteronism

Dr. Centor discusses the diagnosis of primary aldosteronism with Dr. Jordana Cohen.

Jul 14, 202523 min
Copyright 2026 American College of Physicians